Placental accreta diagnosis and outcomes study
Part of Women’s health & pregnancy clinical trials.
This trial looks at how to diagnose and what happens to pregnant women with a condition where the placenta grows too deeply into the uterus (placental accreta). It may help doctors better understand the condition and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old
- You are pregnant and doctors suspect you have placental accreta (placenta growing into the uterus)
- You sign a consent form agreeing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a planned surgical approach for placenta accreta (when the placenta grows too deeply into the uterine wall) in women who have had a previous c-section. If you are at least 28 weeks pregnant and have been diagnosed with this condition, the trial aims to see if a conservative surgery can help safely manage it.
This study follows pregnant women who may have placenta accreta—a condition where the placenta grows too deeply into the uterus. Researchers will measure the length of the cervix and how deeply the placenta is attached using ultrasound to help guide care during pregnancy.
This study looks at placenta accreta spectrum (a serious placenta problem) using ultrasound or MRI images. It may help by classifying the condition in a more detailed way so surgeons can plan the right operation during surgery.
This trial tests a new classification system for placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. It aims to see if this system helps predict outcomes and improve care for pregnant people who need surgery for PAS.
This trial compares two surgical methods for managing placenta accreta spectrum (a condition where the placenta grows too deeply into the uterine wall). It tests whether a less invasive approach (tamponade) works as well as removing part of the uterus (partial myometrial resection) in women having a cesarean section.
This trial studies a simpler, non-surgical approach to managing a condition called morbidly adherent placenta (where the placenta grows too deeply into the uterus). It is for people who are at least 28 weeks pregnant, have placenta previa, and are not having heavy bleeding.
Hear when a new Placenta Accreta trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.